Skip to content
Disclosery

TAKEDA PHARMACEUTICAL CO LTD: DNLI position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of TAKEDA PHARMACEUTICAL CO LTD on DNLI, newest first. How the timeline and the estimate are built.

TAKEDA PHARMACEUTICAL CO LTD held 0 DNLI shares at 2024-09-30 per its 13F-HR filed 2025-02-13.

the latest 13F is the newest step

  1. period ended2024-09-30
    13F 0 shares
    Change vs previous 13F -4,214,559 shares

    13F-HR 0001395064-25-000030 filed by TAKEDA PHARMACEUTICAL CO LTD
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2024-06-30
    13F 4,214,559 shares
    Change vs previous 13F 0 shares

    42.13% of the 13F portfolio, value $97,862,060.

    13F-HR 0001395064-25-000028 filed by TAKEDA PHARMACEUTICAL CO LTD
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2024-03-31
    13F 4,214,559 shares
    Change vs previous 13F 0 shares

    29.92% of the 13F portfolio, value $86,482,751.

    13F-HR 0001395064-25-000026 filed by TAKEDA PHARMACEUTICAL CO LTD
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2023-12-31
    13F 4,214,559 shares
    Change vs previous 13F not available

    26.55% of the 13F portfolio, value $86,946,352.

    13F-HR 0001395064-25-000024 filed by TAKEDA PHARMACEUTICAL CO LTD
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).